Methods and pharmaceutical composition for the treatment of cancer
US10918737B2 · kind B2 · utility
1Cited by
0References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 27, 2017 |
| Grant date | Feb 16, 2021 |
| Priority date | — |
| Expiry date | Aug 26, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and pharmaceutical composition for the treatment of cancer. In particular, the present invention relates to a method for enhancing the potency of an immune checkpoint inhibitor administered to a subject as part of a treatment regimen for cancer, the method comprising: administering a pharmaceutically effective amount of a TNFα blocking agent to a subject in combination with the immune checkpoint inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.